Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:11 PM
Ignite Modification Date: 2025-12-24 @ 11:11 PM
NCT ID: NCT04751669
Eligibility Criteria: Inclusion Criteria: 1. Informed Consent Form signed. 2. Patients with symptoms compatible with COVID-19: cough and fever who not fulfil criteria of hospitalization and will be in outpatient care. 3. Positive polymerase chain reaction (PCR) or transcription-mediated amplification (TMA) test or rapid antigen test for severe acute respiratory syndrome Corona Virus-2 (SARS-CoV-2) or diagnostic test available. 4. Age ≥ 18 years 5. Availability to meet the requirements of the protocol. Exclusion Criteria: 1. Intake of any micronutrient supplement during the month prior to inclusion. 2. Patients fulfilling hospitalization criteria. 3. Previous allergies to the micronutrient components and excipients. 4. Age ≥ 90 years with any comorbidity (diabetes, hypertension, obesity, heart disease, respiratory disease) 5. Participation in other research that requires experimental intervention (does not include observational studies) in the previous month before signing the informed consent form. 6. Detection by the researcher of lack of knowledge or willingness to participate and comply with all the requirements of the protocol. 7. Any other findings that at the discretion of the researcher may compromise protocol performance or significantly influence the interpretation or results of the effects of the nutritional supplement 8. Pregnancy or breastfeeding
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Maximum Age: 90 Years
Study: NCT04751669
Study Brief:
Protocol Section: NCT04751669